With the "Safety Assessment Triad" for PODPs introduced by the PQRI (Product Quality Research Institute) group, the term simulated study was initiated in order to close the gap between extractables and leachables. Presentations featuring simulated studies for both parenterals and ophthalmic will be one of the main topics at this year’s E&L conference. Following the introduction of the draft 510K guideline for infusion pumps by the FDA, describing E&L activities both for pump suppliers and pharmaceutical companies applying drugs for pump use, a direction for E&L activities for infusion systems has also been given.
In addition to discussing this key topic, the conference will also deal with several other E&L related areas such as SUS (Single Use Systems), supply chain challenges, innovation of materials based on E&L knowledge, the role of CRO laboratories and actual E&L strategies for pharmaceutical companies including several case studies as well as health authority expectations.
Dr Carsten Worsoe expressed the following in anticipation of the event: “I feel that depth in the coverage of E&L areas is one of the strengths of this conference and that the conference applies directly to people that are both new to the E&L area as well as to people with high experience.”
For more information visit eandl-conference.com or to enquire about the availability of a press pass contact Daniel Trillo, Pira International, +44 (0)1372 802101, daniel.trillo@
About Pira International
Pira International is the worldwide authority on the packaging, paper and print industry supply chains. Established in 1930, Pira provides strategic and technical consulting, testing, intelligence and events to help clients gain market insights, identify opportunities, evaluate product performance and manage compliance.